Navigation Links
St. John Hospital 1st in Region to Offer Innovative Chemotherapy Delivery System
Date:11/4/2011

DETROIT, Nov. 4, 2011,  /PRNewswire-USNewswire/ -- A unique treatment involving the use of hot chemotherapy is being offered at St. John Hospital and Medical Center. SJH&MC is the first hospital in Southeast Michigan and one of only approximately 20 centers nationwide to offer the treatment.

Know as Hyperthermic Intraperitoneal Chemotherapy, or HIPEC, the procedure has applications for a number of advanced cancers that have spread to the lining of the abdominal cavity, including colorectal, gastric, ovarian, appendiceal, and mesothelioma. For these patients, chemotherapy through a vein can only give them an additional few months to live.

The treatment involves surgically removing cancerous tumors from the abdominal cavity, then bathing the cavity with hot chemotherapy. The surgeon continuously circulates a heated, sterile chemotherapy solution throughout the abdominal cavity for up to two hours, killing remaining cancer cells without damaging normal cells in the body. The solution is then removed and the incision is closed.

Delivering the heated chemotherapy throughout the abdominal cavity distributes the drug thoroughly and allows it to directly penetrate the areas of cancer and reach areas where cancer cells aren't easily visible. Because the chemotherapy is delivered directly to the tumor, many of the side effects associated with intravenous administration of these powerful drugs can be avoided.

"This procedure has been proven to extend the lives of patient's and improve their quality of life," says Richard Berri, M.D., director of surgical oncology at St. John Hospital and one of only surgeons in the world trained to perform the operation. For many patients with advanced cancers that have spread to the abdominal cavity this is their only viable treatment option. Unlike other cancer treatments that only treat the symptoms of abdominal cancers; HIPEC can actually stop the growth of abdominal cancers."

St. John Hospital and Medical Center's Surgical Oncology Program, led by Dr. Berri, provides the most comprehensive and current surgical evaluation and treatment to patients with malignancies that can be treated surgically, including pancreas, liver, colorectal and stomach cancer. SJH&MC also offers the only Peritoneal Malignancies Program in Michigan to offer HIPEC.


'/>"/>
SOURCE St. John Providence Health System
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
2. Gilbert Hospital Continues Cutting Edge Treatments
3. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
4. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
5. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
6. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
7. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
8. Hospital to Hold MRSA Briefing for Media and Community Leaders
9. Arizona Heart Hospital Reaches Settlement Regarding Clinical Research Matter
10. Providence Hospital Study Finds Communication System Leads to Faster Heart Attack Treatment
11. Allegheny General Hospital Performs First Liver Transplant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... 2016   Pairnomix, LLC, a genetic research company ... by the White House, today announced that findings from its ... of candidate therapies for a patient with epileptic encephalopathy caused ... presented at the 70 th Annual Meeting of the ... , December 2-6, 2016.  Pairnomix, unique process ...
(Date:12/4/2016)... , Dec. 3, 2016  Results from the Phase ... an anti-P-selectin antibody, reduced the median annual rate of ... placebo (1.63 vs 2.98, p=0.010) in patients with or ... the data are being featured in the official press ... Hematology (ASH) Annual Meeting and presented during the Plenary ...
(Date:12/4/2016)... 3, 2016  Findings from a Novartis clinical ... an investigational chimeric antigen receptor T cell (CAR ... adult patients with B-cell acute lymphoblastic leukemia (ALL) ... at the 58th American Society of Hematology (ASH) ... The global Phase II study found that 82% ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... 02, 2016 , ... Dr. Raffi Hovsepian, a leading plastic, ... 2016 “Guide to America’s Top Plastic Surgeons” for seven consecutive years. The prestigious ... experience, and professional associations. , One the most frequently honored surgeons in ...
(Date:12/2/2016)... ... 02, 2016 , ... Mediaplanet is proud to announce the ... the innovative treatments, therapeutic technologies, and revolutionized nutrition that are helping patients and ... 6 years in the last 3 decades,” says Dr. Valentine Fuster, a world-renowned ...
(Date:12/2/2016)... ... December 02, 2016 , ... The PAINWeekEnd Regional Conference will ... Spa in Honolulu, offering local frontline clinicians the opportunity to extend their certified ... demand for supplemental training related to pain management has surged dramatically in recent ...
(Date:12/2/2016)... ... 02, 2016 , ... Sourced from the Isbre Springs beneath the 5,000 year ... natural purity of just 6 ppm TDS (Total Dissolved Solids) in addition to its ... available in several ShopRite and FoodTown stores in NJ and received rave comments from ...
(Date:12/2/2016)... ... , ... Yisrayl Hawkins, at The House of Yahweh in Abilene, Texas, has ... Prophecy. Yisrayl says this generation, known as the Last Generation, started in 1934 A.Y. ... line up exactly with Bible Prophecy – a protected way for those who will ...
Breaking Medicine News(10 mins):